EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Annexin A1 as a Key Modulator of Inflammatory, Glial, and Angiogenic Signaling Pathways in Diabetic Retinopathy

Rafael André da Silva, Luiz Philipe de Souza Ferreira, Vinicius Moraes de Paiva Roda, Diego Dias Dos Santos, Caroline Silvério Faria, Barbara Dalmaso, Giovanna Serra da Silva, Carolina Beltrame Del Debbio, Daniel Rodrigues de Bastos, Silvana Sandri, Sandra Helena Poliselli Farsky, Caio Vinicius Saito Regatieri and 1 more

Investigative Ophthalmology & Visual Science · 2026

DOI: 10.1167/iovs.67.10.12 ↗

At a glance

Journal article in Investigative Ophthalmology & Visual Science, 2026. Written by Rafael André da Silva and 12 co-authors. Institution: Biosciences Graduate Program, Institute of Biosciences, Letters and Exact Sciences, UNESP, São José do Rio Preto, SP, Brazil. Major MEDLINE topics: Annexin A1, Diabetic Retinopathy, Signal Transduction, Inflammation. 85 references. The full text is freely available (open access, CC BY 4.0).

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Purpose

Annexin A1 (AnxA1) regulates inflammation and neovascularization in ocular diseases, influencing growth factor signaling and cytoskeletal dynamics. Accordingly, this study aimed to investigate the role of the AnxA1 protein in diabetic retinopathy (DR) and to understand how its absence affects inflammation and vascular dysfunction in DR.

Methods

DR model was induced 12 weeks after streptozotocin injection in wild-type (AnxA1+/+) and AnxA1 knockout (AnxA1-/-) mice. We evaluated the consequences of AnxA1 deficiency on retinal morphology, Müller cell activation, inflammation, and angiogenesis associated with DR. We also performed an in silico analysis in wild-type animals with DR induced for 6 weeks and in a dataset of patients with DR. Furthermore, a choroidal neovascularization model was used to evaluate the role of AnxA1 in angiogenesis signaling.

Results

AnxA1 deficiency exacerbated selective systemic inflammatory alterations and promoted retinal neurodegeneration associated with DR. AnxA1-/- diabetic animals exhibited increased circulating IL-6, IL-17, chemokine (C-X-C motif) ligand 1, and monocyte chemoattractant protein-1 levels, retinal monocyte chemoattractant protein-1 and IL-4 upregulation, dysregulated MAPK/STAT3 signaling, and altered gliosis responses. In addition, AnxA1 deficiency was associated with a proangiogenic signaling profile characterized by increased retinal levels of EGF, VEGF-A, and endothelin-1 in DR, whereas the upregulation of VEGF-C was predominantly observed in the choroidal neovascularization model.

Conclusions

Endogenous AnxA1 modulates inflammatory-glial and proangiogenic signaling pathways in the diabetic retina. Its deficiency is associated with selective inflammatory dysregulation and enhanced angiogenesis-related signaling during DR progression.

Subjects

MeSH terms (MEDLINE)

Annexin A1Diabetic RetinopathySignal TransductionInflammationEpendymoglial CellsAnimalsMiceDiabetes Mellitus, ExperimentalMice, KnockoutMice, Inbred C57BLMaleDisease Models, AnimalHumansBlotting, WesternVascular Endothelial Growth Factor A

Substances

Annexin A1annexin A1, mouseVascular Endothelial Growth Factor A

Authors and institutions

  • Biosciences Graduate Program, Institute of Biosciences, Letters and Exact Sciences, UNESP, São José do Rio Preto, SP, Brazil.
  • Department of Morphology and Genetics, Escola Paulista de Medicina, Universidade Federal de São Paulo (EPM/UNIFESP), São Paulo, SP, Brazil.
  • Laboratory of Immunology, Heart Institute (InCor), Universidade de São Paulo, São Paulo, Brazil.
  • Laboratorio de Investigacao Medica (LIM03), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, Universidade de Sao Paulo, SP, Brazil.
  • Department of Cell and Developmental Biology, Biomedical Sciences Institute, University of Sao Paulo, Sao Paulo, Brazil.
  • Facultad de Ciencias Médicas, Universidad Privada del Este filial Ciudad del Este, Paraguay.

Cite

APA

da Silva, R. A., Ferreira, L. P. S., Roda, V. M. P., Dos Santos, D. D., Faria, C. S., Dalmaso, B., da Silva, G. S., Del Debbio, C. B., Bastos, D. R., Sandri, S., Farsky, S. H. P., Regatieri, C. V. S., & Gil, C. D. (2026). Annexin A1 as a Key Modulator of Inflammatory, Glial, and Angiogenic Signaling Pathways in Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. https://doi.org/10.1167/iovs.67.10.12

Vancouver

da Silva RA, Ferreira LPS, Roda VMP, Dos Santos DD, Faria CS, Dalmaso B, et al. Annexin A1 as a Key Modulator of Inflammatory, Glial, and Angiogenic Signaling Pathways in Diabetic Retinopathy. Investigative Ophthalmology & Visual Science. 2026. doi:10.1167/iovs.67.10.12

BibTeX
@article{daSilva2026,
  author = {da Silva, Rafael André and Ferreira, Luiz Philipe de Souza and Roda, Vinicius Moraes de Paiva and Dos Santos, Diego Dias and Faria, Caroline Silvério and Dalmaso, Barbara and da Silva, Giovanna Serra and Del Debbio, Carolina Beltrame and Bastos, Daniel Rodrigues de and Sandri, Silvana and Farsky, Sandra Helena Poliselli and Regatieri, Caio Vinicius Saito and Gil, Cristiane Damas},
  title = {Annexin A1 as a Key Modulator of Inflammatory, Glial, and Angiogenic Signaling Pathways in Diabetic Retinopathy},
  journal = {Investigative Ophthalmology & Visual Science},
  year = {2026},
  doi = {10.1167/iovs.67.10.12}
}
Start for free →